253 publications

Enter search criteria

Fill in keyword(s) to narrow your search.

Periode

Fill in a starting date and a closing date for the period your query is about: DD-MM-YYYY

You can select a specific type of a publication you are looking for, such as press releases or speeches

Ciclosporin (Ikervis®) for the treatment of severe keratitis in adult patients with the dry eye syndrome

Zorginstituut Nederland has completed its assessment whether ciclosporin (Ikervis®) for the treatment of severe keratitis in ...

Report | 18-09-2019

Dabrafenib/trametinib (Tafinlar®/Mekinist®) for the adjuvant treatment of adult patients with stage III melanoma

Zorginstituut Nederland has completed its assessment of dabrafenib (Tafinlar®) in combination with trametinib (Mekinist®) for the ...

Report | 28-08-2019

Explanation of the Interest Form - MEB-ZIN Parallel Procedures pilot

Accelerating patient access to reimbursable innovative medicines has been on the wish list of the government, patient ...

Publication | 18-07-2019

Erenumab (Aimovig®) for the prophylaxis of adults with migraine

Zorginstituut Nederland has completed its assessment whether erenumab (Aimovig®) for the prophylaxis of adults with migraine, can ...

Report | 27-06-2019

Ipilimumab/nivolumab (Yervoy®/Opdivo®) for the first-line treatment of adult patients with intermediate/poor-risk advanced renal cell carcinoma

Zorginstituut Nederland has completed its assessment whether ipilimumab/nivolumab (Yervoy®/Opdivo®) for the first-line treatment ...

Report | 29-05-2019

Venetoclax (Venclyxto®) in combination with rituximab for the treatment of chronic lymphocytic leukaemia (CLL)

Zorginstituut Nederland has completed its assessment whether venetoclax (Venclyxto®) in combination with rituximab for the ...

Report | 08-05-2019

Lumacaftor/ivacaftor (Orkambi®) for the treatment of cystic fibrosis

Zorginstituut Nederland carried out a marginal assessment in relation to extending the specific conditions for the medicinal ...

Report | 30-04-2019

Tezacaftor/ivacaftor (Symkevi®) with ivacaftor monopreparation (Kalydeco®) for the treatment of cystic fibrosis

Zorginstituut Nederland carried out an assessment in relation to extending the specific conditions for the medicinal product ...

Report | 24-04-2019

Assessment of 'established medical science and medical practice’ - a technical modification

This report is a supplement to the existing Dutch assessment framework dating form 2015. It can be used to investigate whether an ...

Report | 23-04-2019

Brexpiprazole (Rxulti®) for the treatment of schizophrenia in adults

Zorginstituut Nederland carried out a marginal assessment whether the product brexpiprazole (Rxulti®) can be accepted into the ...

Report | 16-04-2019